Legislative Tracker – Drug Pricing – March 2025

Updated through August 2025, this tracker from The Council and Steptoe LLP catalogs active 119th Congress legislation on prescription drug pricing and transparency. It covers single-issue bills targeting price transparency, drug importation, price gouging, and PBM reforms, as well as multi-issue legislation tied to broader healthcare reform. Newly included bills include the PBM Reform Act of 2025, the Reducing Drug Prices for Seniors Act, and the Repealing the Trump Sick Tax Act, along with a summary of enacted legislation from the current Congress.

Established in 2004, Leader's Edge is our award-winning content platform, covering legal and legislative issues, international business and regulation, management trends and best practices, technology, and more.

Visit Leader's Edge Magazine

October 31, 2024

The Price of Pharma Promotion

The Price of Pharma Promotion Direct-to-consumer pharmaceutical advertising has a real impact on employer drug costs. What can be done to rein in its effects?

March 3, 2026

No More PBM Surprises

No More PBM Surprises The Consolidated Appropriations Act of 2026 improves PBM transparency and takes an important step toward reducing prescription drug costs.

June 27, 2016

Protection Money

Protection Money Three billion dollars in protection money buys “obscene profits” on specialty drugs for Big Pharma. Now it’s killing your clients’ businesses.

Visit Leader's Edge Magazine

Grow faster. Lead smarter.

Get access to all of the insights, tools, and connections to help you rise.

Create an account Login

Legislative Tracker – Drug Pricing – March 2025

The Price of Pharma Promotion

No More PBM Surprises

Protection Money

Grow faster. Lead smarter.

Make sure you don't miss a beat.